[1]
Anjum, S. et al. 2021. RANKL Signaling Pathway: A Potential Target for Antiresorptive Therapy in Rheumatoid Arthritis. NUST Journal of Natural Sciences. 3, 1 (Feb. 2021), 35–52. DOI:https://doi.org/10.53992/njns.v3i1.20.